Skip to content

Tyler G. Ekins

4 papers in the library · 26 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

A Single Dose of a Psychedelic Drug Repairs Prefrontal Cortex Synaptic Physiology in a Mouse Model of Prenatal Alcohol Exposure.

Brain and Behavior April 1, 2026 Tyler G. Ekins, Tao Deng, Omar J. Ahmed

Background: Prenatal alcohol exposure (PAE) can cause fetal alcohol spectrum disorders (FASDs), which are characterized by neural circuit and behavioral dysfunction due to impaired brain development. At the neural and behavioral levels, PAE is associated with disrupted cortical synaptic transmission and lifelong impairments in learning and cognitive control. Despite the prevalence of FASDs...

DOI: 10.1002/brb3.71406 (opens in new tab) Full text (opens in new tab) Pyramidal cells Prefrontal cortex Synapses Animals +15

Psychedelic neuroplasticity of cortical neurons lacking 5-HT2A receptors

Molecular Psychiatry March 1, 2026 Tyler G. Ekins, Chloe Rybicki-Kler, Tao Deng et al. 9 citations

Classical psychedelic drugs show promise as a treatment for major depressive disorder and related psychiatric disorders. This therapeutic efficacy stems from long-lasting psychedelic-induced neuroplasticity onto prefrontal cortical neurons and is thought to require the postsynaptic expression of serotonin 2A receptors (5-HT_2AR). However, other cortical regions such as the granular...

Single-dose psychedelic enhances cognitive flexibility and reversal learning in mice weeks after administration.

Psychedelics April 22, 2025 Elizabeth J. Brouns, Tyler G. Ekins, Omar J. Ahmed

Psychedelic compounds have demonstrated remarkable therapeutic potential for treating neuropsychiatric disorders by promoting sustained neuroplasticity in the prefrontal cortex (PFC). Cognitive flexibility-the ability to adapt previously learned rules to novel situations-represents a critical PFC function that is frequently impaired in depression, PTSD, and neurodegenerative conditions. In this...

Cellular rules underlying psychedelic control of prefrontal pyramidal neurons

bioRxiv (Cold Spring Harbor Laboratory) October 23, 2023 Tyler G. Ekins, Isla A. W. Brooks, Sameer Kailasa et al. 17 citations preprint

ABSTRACT Classical psychedelic drugs are thought to increase excitability of pyramidal cells in prefrontal cortex via activation of serotonin 2 A receptors (5-HT2 A Rs). Here, we instead find that multiple classes of psychedelics dose-dependently suppress intrinsic excitability of pyramidal neurons, and that extracellular delivery of psychedelics decreases excitability significantly more than...

DOI: 10.1101/2023.10.20.563334 (opens in new tab) Full text (opens in new tab) Serotonin Prefrontal cortex Consumer neuroscience Pyramidal cell +2